Event

J. Terrill. Huggins

MD
Medical University of South Carolina

Monica Bengus

MD
F. Hoffmann-La Roche Ltd.;F. Hoffmann-La Roche, Ltd.

Hilario Nunes

MD, PhD
Hôpital Avicenne;Hôpital Avicenne, AP-HP

Claudia Valenzuela

DrMed
Hospital Universitario de la Princesa;Hospital Universitario de La Princesa, Instituto de Investigación Princesa;Hospital Universitario La Princesa

Marlies Wijsenbeek

MD, PhD
Erasmus MC, University Medical Centre;Erasmus Medical Center;Erasmus University Medical Center

Charlene D. Fell

MD, MSc, FRCPC, FCCP
University of Calgary

Ute Petzinger

MD
Clinipace-Accovion GmbH

John L. Stauffer

MD
Genentech;Genentech, Inc.

Kevin Flaherty

MD
University of Michigan

Frank Gilberg

PhD
F. Hoffmann-La Roche Ltd.;F. Hoffmann-La Roche, Ltd.

Robert Sussman

MD
Atlantic Health System, Overlook Medical Center

Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)